Unternehmen auf Beobachtungsliste setzen
Symrise AG
ISIN:
DE000SYM9999
WKN:
SYM999
Land: Deutschland
·
Primärmarkt: Deutschland
·
EQS NID: 1848477
Levermann Score
29 Februar 2024 12:23PM
Dr Heinz-Jürgen Bertram hands over to Dr Jean-Yves Parisot
EQS-Ad-hoc: Symrise AG / Key word(s): Personnel Holzminden, 29 February 2024
Dr Jean-Yves Parisot has been a member of the Executive Board of Symrise AG since 2016, being responsible for the Taste, Nutrition & Health segment. He takes over as CEO from Dr Heinz-Jürgen Bertram, whose contract originally would have expired by end of October 2025 and who is now retiring in the best mutual consent and agreement. He will continue to work closely with Dr Jean-Yves Parisot to ensure a smooth handover. www.symrise.com Media contact: Investor Relations contact: Bernhard Kott Tobias Erfurth Tel.: +49 55 31 90-17 21 Tel.: +49 55 31 90-1879 Email: bernhard.kott@symrise.com Email: Tobias.Erfurth@symrise.com End of Inside Information
29-Feb-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Symrise AG |
Mühlenfeldstraße 1 | |
37603 Holzminden | |
Germany | |
Phone: | +49 (0)5531 90 0 |
E-mail: | ir@symrise.com |
Internet: | www.symrise.com |
ISIN: | DE000SYM9999, DE000SYM7787, DE000SYM7704 |
WKN: | SYM999 |
Indices: | DAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1848477 |
End of Announcement | EQS News Service |
|
1848477 29-Feb-2024 CET/CEST